The global dialysis equipment market is on a strong growth trajectory, with projected sales expected to increase from USD 11,126.0 million in 2024 to an impressive USD 17,780.9 million by 2034. This represents a compound annual growth rate (CAGR) of 4.8% over the forecast period, underscoring the rising demand for advanced dialysis solutions to support a growing patient population.
In 2023, revenue from dialysis equipment reached USD 10.6 billion, establishing a solid foundation for future expansion. This upward trend is primarily fueled by the rising incidence of end-stage renal disease (ESRD), a severe health condition affecting millions worldwide. As ESRD patients rely on dialysis for essential kidney filtration, the need for reliable, effective dialysis equipment continues to grow. Chronic conditions like type 2 diabetes and hypertension, if unmanaged, can lead to ESRD, creating further demand for dialysis treatment options globally.
An aging global population is also a significant driver of market growth. Age-related decline in kidney function is common, leading to an increased need for dialysis as individuals face associated health complications. As the elderly population expands, the demand for sophisticated dialysis equipment capable of improving patient quality of life is expected to grow.
The dialysis equipment market is essential to managing ESRD, and it’s advancing with new technologies aimed at enhancing treatment efficiency and patient comfort. By meeting the needs of a broadening patient demographic, the market is poised to play an instrumental role in addressing global renal health challenges and improving patient outcomes.
With its sustained growth, the global dialysis equipment market stands as a crucial component in the ongoing fight against renal diseases and offers hope for improved patient care worldwide.
Key Takeaways
- The global sales of dialysis equipment are projected to grow at a CAGR of 4.8% from 2024 to 2034, reaching a value of USD 17,780.9 million by 2034.
- Regional Market Trends:
- The US market is expected to grow at a CAGR of 1.5% during the forecast period.
- Germany holds a significant share of the market.
- China's market is anticipated to grow at a CAGR of 4.3% overall, with a faster growth rate of 6.6% projected from 2024 to 2034.
Discover the Rising Demand for Dialysis Equipment: Dive into Our Full Report for Detailed Trends and Insights! https://www.prnewswire.com/news-releases/dialysis-equipment-market-likely-to-reach-a-valuation-of-us-236-bn-by-2028-end---future-market-insights-686136691.html
Competitive Landscape:
Substantial investments are being directed towards research and development in the dialysis equipment industry to drive innovation, enhance product differentiation with advanced features, and improve patient outcomes. Companies in this sector are also focusing on forming strategic partnerships to strengthen their product portfolios and expand their global market presence.
Recent Industry Developments in the Dialysis Equipment Market:
- May 2024: Asahi Kasei acquired Calliditas Therapeutics AB to accelerate its growth as a global healthcare leader.
- July 2023: Baxter International Inc., a leading medtech company, announced the creation of a new entity named Vantive, which will focus on its Renal Care and Acute Therapies businesses. This development is set to position Vantive as a specialized company dedicated to therapies for kidney disease and other vital organ support.
- November 2021: B. Braun Avitum AG, a key player in extracorporeal blood treatment systems, acquired Nephtec GmbH. This acquisition has enhanced B. Braun Avitum’s product portfolio in the central preparation of dialysis concentrates.
Key Players of Dialysis Equipment Market:
- Baxter
- Asahi Kasei Corporation
- Fresenius Medical Care AG Co. KGaA
- Cantel Medical
- Rockwell Medical
- JMS Co.Ltd.
- Teleflex Incorporated
- B. Braun Melsungen AG
- NIPRO
- HEMOCLEAN CO., LTD.
- Quanta
- Outset Medical, Inc.
Key Segments of Dialysis Equipment Market:
By Product:
In terms of product, the industry is divided into haemodialysis devices (haemodialysis machines, dialyzers and filters, vascular access devices), peritoneal dialysis devices (dialyzers and filters, vascular access devices) and continuous renal replacement therapy.
By Disease Condition:
In terms of disease condition, the industry is segregated into chronic and acute.
By End Use:
In terms of end use, the industry is segregated into hospitals, clinics, ambulatory surgical centres and home care settings.
By Region:
Key countries of North America, Latin America, Western Europe, Eastern, South Asia and Pacific, East Asia and Middle East and Africa (MEA) have been covered in the report.